New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
Geena Sutherland, MD
Advertisement
Dr Sutherland is a first-year psychiatry resident at Creighton University in Omaha, Nebraska.
Articles by Geena Sutherland, MD
Advertisement
Latest Updated Articles
Benzodiazepine Discontinuation Associated With Increased Mortality in Patients on Stable, Long-Term BenzodiazepinesPublished: April 16th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
2
Preliminary Report on Dangers of AI Chatbots
3
Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
